ES554245A0 - Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia - Google Patents

Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia

Info

Publication number
ES554245A0
ES554245A0 ES554245A ES554245A ES554245A0 ES 554245 A0 ES554245 A0 ES 554245A0 ES 554245 A ES554245 A ES 554245A ES 554245 A ES554245 A ES 554245A ES 554245 A0 ES554245 A0 ES 554245A0
Authority
ES
Spain
Prior art keywords
pirimidin
preparing
procedure
leukemia activity
carboxamides substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554245A
Other languages
English (en)
Other versions
ES8800671A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIROYAL Ltd
Uniroyal Chemical Co Inc
Original Assignee
UNIROYAL Ltd
Uniroyal Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIROYAL Ltd, Uniroyal Chemical Co Inc filed Critical UNIROYAL Ltd
Publication of ES8800671A1 publication Critical patent/ES8800671A1/es
Publication of ES554245A0 publication Critical patent/ES554245A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES554245A 1985-04-22 1986-04-22 Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia Expired ES8800671A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,736 US4636508A (en) 1985-04-22 1985-04-22 5-pyrimidinecarboxyamides and treatment of leukemia therewith

Publications (2)

Publication Number Publication Date
ES8800671A1 ES8800671A1 (es) 1987-11-16
ES554245A0 true ES554245A0 (es) 1987-11-16

Family

ID=24915762

Family Applications (3)

Application Number Title Priority Date Filing Date
ES554245A Expired ES8800671A1 (es) 1985-04-22 1986-04-22 Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia
ES557683A Expired ES8801219A1 (es) 1985-04-22 1987-08-19 Procedimiento para preparar 5-pririmidin-carboxamidas sustituidas con actividad anti-leucemia.
ES557684A Expired ES8801220A1 (es) 1985-04-22 1987-08-19 Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividadd anti-leucemia.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557683A Expired ES8801219A1 (es) 1985-04-22 1987-08-19 Procedimiento para preparar 5-pririmidin-carboxamidas sustituidas con actividad anti-leucemia.
ES557684A Expired ES8801220A1 (es) 1985-04-22 1987-08-19 Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividadd anti-leucemia.

Country Status (21)

Country Link
US (1) US4636508A (es)
JP (1) JPS6259264A (es)
CN (2) CN1014990B (es)
AT (1) AT391864B (es)
AU (3) AU592559B2 (es)
BE (1) BE904641A (es)
CA (1) CA1274509A (es)
CH (1) CH668970A5 (es)
DE (1) DE3613447A1 (es)
DK (1) DK182986A (es)
ES (3) ES8800671A1 (es)
FR (1) FR2580642B1 (es)
GB (1) GB2174391B (es)
GR (1) GR861024B (es)
IL (2) IL78576A0 (es)
IT (1) IT1214499B (es)
LU (1) LU86403A1 (es)
NL (1) NL8601023A (es)
NZ (1) NZ215874A (es)
SE (1) SE8601826L (es)
ZA (1) ZA862630B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
FR2628741A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd Nouveaux composes n-phenyl-5-pyrimidinecarboxamides et composition pharmaceutique les contenant utilisable pour induire la regression de la leucemie ou des tumeurs
FR2628869A1 (es) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd
EP0430885A3 (en) * 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
WO2003035076A1 (en) * 2001-10-26 2003-05-01 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
US9428466B2 (en) * 2013-11-13 2016-08-30 Raymond P. Warrell, Jr. Methods for reducing uric acid levels using barbiturate derivatives
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
EP3247704A4 (en) 2015-01-22 2018-10-03 Acquist LLC Bifunctional compounds and use for reducing uric acid levels
TWI772309B (zh) 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
WO2018009615A1 (en) 2016-07-06 2018-01-11 Acquist Llc Compounds and their use for reducing uric acid levels
WO2018200571A1 (en) 2017-04-25 2018-11-01 Arbutus Biopharma Corporation Substituted 2,3-dihydro-1h-indene analogs and methods using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670756A1 (de) * 1966-10-05 1970-12-23 Hoechst Ag Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
DE2719777A1 (de) * 1976-05-06 1977-11-24 Ciba Geigy Ag Neue 5-phenylcarbamoyl-barbitursaeuren
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
JPS5625166A (en) * 1979-08-09 1981-03-10 Banyu Pharmaceut Co Ltd 5-fluorouracil derivative
JPS5843960A (ja) * 1981-09-10 1983-03-14 Shoichiro Ozaki 5−フルオロウラシル誘導体,その製造法および制ガン剤
DE3347795A1 (de) * 1983-01-14 1985-08-01 Ozaki, Shoichiro, Ehime Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind
JPS6012322A (ja) * 1983-07-01 1985-01-22 Toyota Motor Corp 四リンク型サスペンシヨン
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU592559B2 (en) 1990-01-18
ATA101986A (de) 1990-06-15
DK182986A (da) 1986-10-23
CH668970A5 (de) 1989-02-15
AU5641886A (en) 1986-10-30
GR861024B (en) 1986-08-14
IT8620153A0 (it) 1986-04-18
CN1014990B (zh) 1991-12-04
DK182986D0 (da) 1986-04-21
NL8601023A (nl) 1986-11-17
GB2174391B (en) 1988-12-29
CN1038450A (zh) 1990-01-03
BE904641A (fr) 1986-10-21
DE3613447A1 (de) 1986-10-30
IT1214499B (it) 1990-01-18
JPS6259264A (ja) 1987-03-14
IL86711A0 (en) 1988-11-30
ES8801219A1 (es) 1987-12-16
SE8601826D0 (sv) 1986-04-21
GB2174391A (en) 1986-11-05
US4636508A (en) 1987-01-13
ES8801220A1 (es) 1988-01-01
FR2580642A1 (fr) 1986-10-24
DE3613447C2 (es) 1991-04-11
ES557684A0 (es) 1988-01-01
NZ215874A (en) 1988-09-29
ES557683A0 (es) 1987-12-16
AU2219588A (en) 1989-01-05
ES8800671A1 (es) 1987-11-16
LU86403A1 (fr) 1987-12-07
AT391864B (de) 1990-12-10
GB8609244D0 (en) 1986-05-21
SE8601826L (sv) 1986-10-23
CN86102767A (zh) 1987-01-07
CA1274509A (en) 1990-09-25
FR2580642B1 (fr) 1988-12-30
ZA862630B (en) 1986-11-26
AU2219688A (en) 1989-01-05
IL78576A0 (en) 1986-08-31

Similar Documents

Publication Publication Date Title
ES557241A0 (es) Procedimiento para preparar nuevos 2-aril-imidazoles
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES557210A0 (es) Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES556173A0 (es) Procedimiento para preparar derivados de acido acrilico con actividad fungicida
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
ES551807A0 (es) Procedimiento para preparar piridinil acilhidrazonas
ES550896A0 (es) Procedimiento para preparar espiro-dioxolanos-ditiolanos y oxotiolanos
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES554245A0 (es) Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia
ES550875A0 (es) Procedimiento para preparar derivados de imidazolilalquil- quilguanidina
ES555561A0 (es) Procedimiento para preparar celalosporinas
ES554112A0 (es) Procedimiento para preparar compuestos de ciclohexil y cicloexenil-imidazol
MX162986B (es) Procedimiento para preparar n-formil-alfa-aspartil-fenilalanina
MX160612A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles
ES548237A0 (es) Procedimiento para preparar n6-bicicloadenosinas
ES544622A0 (es) Procedimiento para preparar l-fenilalamina
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES552840A0 (es) Procedimiento para preparar disulfuros heterociclicos
MX159907A (es) Procedimiento para preparar cloro-o-nitroanilinas
MX162329A (es) Procedimiento para preparar acilhidrazonas sulfeniladas
ES555042A0 (es) Procedimiento para preparar diazepinoindoles
ES546647A0 (es) Procedimiento para preparar pseudooligosacaridos
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina
ES284884Y (es) Estructura desmontable para tuneles-invernaderos

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506